Amarna Therapeutics Secures Additional €5 ($5.7) Million To Advance Its Transformative Gene Therapy Platform Towards Clinical Trials
Amount Raised
€5 Million
Round Type
Funding Round
LeidenManufacturingBiotechnologyHealth CareScience And EngineeringBiopharmaDescription
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, today announced that it has secured a further €4 million from existing investors C4 holding BV and Flerie Invest AB, as well as € 1 million of additional innovation credit funding from RVO, the Netherlands Enterprise Agency. The funds will enable Amarna to advance its lead gene therapy for the treatment of hemophilia B towards a first-in-human clinical trial, and to progress its R&D pipeline in selected autoimmune diseases and chronic inflammation.
Quick answer
Amarna Therapeutics raised €5 Million in a Funding Round round, dated December 1, 2021. Amarna Therapeutics is based in Leiden, South Holland, Netherlands.
- How much did Amarna Therapeutics raise?
- Amarna Therapeutics raised €5 Million in a Funding Round round on December 1, 2021.
- What does Amarna Therapeutics do?
- Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of rare and prevalent diseases.
- Where is Amarna Therapeutics based and how big is it?
- Amarna Therapeutics is based in Leiden, South Holland, Netherlands.
- Who are the decision-makers at Amarna Therapeutics?
- Fundz holds 1 contact at Amarna Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biopharma around the same time
Companies in the same sectors as Amarna Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- AnHeart Therapeutics raised $61M (Series B) on December 14, 2021.
- Co-Diagnostics, Inc. raised $47M on January 14, 2022.
- RedHill Biopharma Ltd raised $5M on November 22, 2021.
- RedHill Biopharma Ltd raised an undisclosed amount (Corporate Round) on November 8, 2021.
- PostEra Inc. raised $26M on January 14, 2022.
- MycoWorks, Inc. raised $125M (Series C) on January 13, 2022.
Who to call at Amarna Therapeutics, and when
A new round usually means Amarna Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amarna Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amarna Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amarna Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amarna Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Amarna Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.